FierceBiotech | Nachrichten

Zeit	Aktuelle Nachrichten
15:42	Anima, Eli Lilly pen $1B-plus biobucks research pact
12:42	Human Longevity accuses J. Craig Venter of stealing secrets
Fr	Insilico and A2A launch new Duchenne-focused AI drug company
Fr	Boston Scientific's spree continues with $270M deal for Claret and its TAVR safety net
Fr	PTC inks $200M Agilis takeover to snag late-phase gene therapy
Fr	Patient death prompts FDA hold on Mersana's lead cancer ADC
Fr	Roche, PureTech team up develop oral antisense oligonucleotides
Fr	Chutes & Ladders-Human Longevity CFO/COO departs after scandal
Do	Smiths Group's stock price falls after EU medical device decertifications
Do	EuroBiotech Report-Sanofi, Novartis and Gilead strike deals, Amgen-UCB and Brexit
Do	EuroBiotech: More Articles of Note
Do	An eye drop for macular degeneration shows promise in animal studies
Do	Hospital antibiotic developer Aridis files for $34.5M IPO
Do	Gritstone, Bristol-Myers Squibb to trial immunotherapy combos in solid tumors
Do	Stripped-down Vical 'considering options' after pipeline woes
Do	Could a chili pepper derivative used for pain also help fight obesity?
Do	Novartis pays €95M to bag dermatitis drug from Galapagos, MorphoSys
Do	Gilead's Kite bags option to buy gamma delta startup Gadeta
Do	IFM Therapeutics' inflammation-focused subsidiary debuts with $31M
Do	IBM and the VA extend their Watson collaboration in guiding veterans' cancer treatments
Mi	Stroke detection software developer Viz.ai brings in $21M in series A round
Mi	Johns Hopkins startup Neuraly plans phase 1 Parkinson's trial with $36M round
Mi	CRO Novotech inks partnership deal with the Asian Eye Institute
Mi	Ovid, Takeda add 2 rare epilepsies to rare drug pact
Mi	Bill Gates and others launch $30M 'venture philanthropy' accelerator for Alzheimer's diagnostics

Zeit

Aktuelle Nachrichten

15:42

Anima, Eli Lilly pen $1B-plus biobucks research pact

12:42

Human Longevity accuses J. Craig Venter of stealing secrets

Insilico and A2A launch new Duchenne-focused AI drug company

Boston Scientific's spree continues with $270M deal for Claret and its TAVR safety net

PTC inks $200M Agilis takeover to snag late-phase gene therapy

Patient death prompts FDA hold on Mersana's lead cancer ADC

Roche, PureTech team up develop oral antisense oligonucleotides

Chutes & Ladders-Human Longevity CFO/COO departs after scandal

Smiths Group's stock price falls after EU medical device decertifications

EuroBiotech Report-Sanofi, Novartis and Gilead strike deals, Amgen-UCB and Brexit

EuroBiotech: More Articles of Note

An eye drop for macular degeneration shows promise in animal studies

Hospital antibiotic developer Aridis files for $34.5M IPO

Gritstone, Bristol-Myers Squibb to trial immunotherapy combos in solid tumors

Stripped-down Vical 'considering options' after pipeline woes

Could a chili pepper derivative used for pain also help fight obesity?

Novartis pays €95M to bag dermatitis drug from Galapagos, MorphoSys

Gilead's Kite bags option to buy gamma delta startup Gadeta

IFM Therapeutics' inflammation-focused subsidiary debuts with $31M

IBM and the VA extend their Watson collaboration in guiding veterans' cancer treatments

Stroke detection software developer Viz.ai brings in $21M in series A round

Johns Hopkins startup Neuraly plans phase 1 Parkinson's trial with $36M round

CRO Novotech inks partnership deal with the Asian Eye Institute

Ovid, Takeda add 2 rare epilepsies to rare drug pact

Bill Gates and others launch $30M 'venture philanthropy' accelerator for Alzheimer's diagnostics

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von FierceBiotech